These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

232 related articles for article (PubMed ID: 20017828)

  • 41. Ultrafiltration without dialysis for removal of fluid and solutes in uremia.
    Bergström J
    Clin Nephrol; 1978 Apr; 9(4):156-64. PubMed ID: 648043
    [TBL] [Abstract][Full Text] [Related]  

  • 42. International Quotidian Dialysis Registry: annual report 2009.
    Nesrallah GE; Suri RS; Moist LM; Cuerden M; Groeneweg KE; Hakim R; Ofsthun NJ; McDonald SP; Hawley C; Caskey FJ; Couchoud C; Awaraji C; Lindsay RM
    Hemodial Int; 2009 Jul; 13(3):240-9. PubMed ID: 19703054
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Economic evaluation of dialysis therapies.
    Klarenbach S; Manns B
    Semin Nephrol; 2009 Sep; 29(5):524-32. PubMed ID: 19751898
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Techniques of continuous arteriovenous hemofiltration and hemodialysis. Renal replacement in the ICU for hypervolemic, uremic patients.
    Merrill RH
    J Crit Illn; 1991 Apr; 6(4):381-7. PubMed ID: 10147916
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Quantifying daily hemodialysis.
    Depner TA; Bhat A
    Semin Dial; 2004; 17(2):79-84. PubMed ID: 15043606
    [TBL] [Abstract][Full Text] [Related]  

  • 46. The effects of intradialytic exercise on hemodialysis adequacy: A systematic review.
    Kirkman DL; Scott M; Kidd J; Macdonald JH
    Semin Dial; 2019 Jul; 32(4):368-378. PubMed ID: 30968465
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Short dialysis, middle molecules, and uremia.
    Nolph KD
    Ann Intern Med; 1977 Jan; 86(1):93-7. PubMed ID: 835933
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Reduction in protein-bound solutes unacceptable as marker of dialysis efficacy during alternate-night nocturnal hemodialysis.
    Meijers B; Toussaint ND; Meyer T; Bammens B; Verbeke K; Vanrenterghem Y; Kerr PG; Evenepoel P
    Am J Nephrol; 2011; 34(3):226-32. PubMed ID: 21791919
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Intensive hemodialysis: normalizing the "unphysiology" of conventional hemodialysis?
    Curran SP; Chan CT
    Semin Dial; 2011; 24(6):607-13. PubMed ID: 22122548
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Extracorporeal removal of uremic toxins: can we still do better?
    Eloot S; Ledebo I; Ward RA
    Semin Nephrol; 2014 Mar; 34(2):209-27. PubMed ID: 24780474
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Classification of Uremic Toxins and Their Role in Kidney Failure.
    Rosner MH; Reis T; Husain-Syed F; Vanholder R; Hutchison C; Stenvinkel P; Blankestijn PJ; Cozzolino M; Juillard L; Kashani K; Kaushik M; Kawanishi H; Massy Z; Sirich TL; Zuo L; Ronco C
    Clin J Am Soc Nephrol; 2021 Dec; 16(12):1918-1928. PubMed ID: 34233920
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Obstacles to reducing plasma levels of uremic solutes by hemodialysis.
    Sirich TL
    Semin Dial; 2017 Sep; 30(5):403-408. PubMed ID: 28558415
    [TBL] [Abstract][Full Text] [Related]  

  • 53. How can we improve the solute and fluid transport prescriptions in hemodialysis to improve patient outcomes?
    Gotch F; Kotanko P; Levin N
    Blood Purif; 2013; 35(1-3):93-105. PubMed ID: 23343553
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Chronic complications in hemodialysis: correlations with primary renal disease.
    Checheriţă IA; Turcu F; Dragomirescu RF; Ciocâlteu A
    Rom J Morphol Embryol; 2010; 51(1):21-6. PubMed ID: 20191115
    [TBL] [Abstract][Full Text] [Related]  

  • 55. [The intradialytic kinetics of uremic toxins in the diffusion-convection hemodialysis method].
    Navino C; Barbè MC; Chiarinotti D; Guida GE; Cusaro C; Fortina A; De Leo M; Pecora S; Verzetti G
    Minerva Urol Nefrol; 1990; 42(1):13-6. PubMed ID: 2202067
    [TBL] [Abstract][Full Text] [Related]  

  • 56. A critical assessment of uremia research.
    Locatelli F; Di Filippo S; Pozzoni P
    Blood Purif; 2006; 24(1):71-6. PubMed ID: 16361845
    [TBL] [Abstract][Full Text] [Related]  

  • 57. What is uremia? Retention versus oxidation.
    Vanholder R; Schepers E; Meert N; Lameire N
    Blood Purif; 2006; 24(1):33-8. PubMed ID: 16361838
    [TBL] [Abstract][Full Text] [Related]  

  • 58. [Hemodialysis in patients with chronic renal insufficiency].
    Canaud B; Leray-Moragués H; Chenine-Koualef L; Patrier L
    Rev Prat; 2012 Jan; 62(1):53-61. PubMed ID: 22335068
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Dialysis prescription: A modifiable risk factor for chronic kidney disease patients.
    Canaud B; Wabel P; Tetta C
    Blood Purif; 2010; 29(4):366-74. PubMed ID: 20389066
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Future Avenues to Decrease Uremic Toxin Concentration.
    Vanholder RC; Eloot S; Glorieux GL
    Am J Kidney Dis; 2016 Apr; 67(4):664-76. PubMed ID: 26500179
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.